Cangfu Daotan Wan alleviates polycystic ovary syndrome with phlegm-dampness syndrome via disruption of the PKP3/ERCC1/MAPK axis

BACKGROUND/AIM: Cangfu Daotan Wan (CFDTW) has been widely used for polycystic ovary syndrome (PCOS) patients in the type of stagnation of phlegm and dampness. In this study, we aimed to evaluate the mechanism underlying the therapeutic effect of CFDTW on PCOS with phlegm-dampness syndrome (PDS). MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuan, Wu, Haicui, Guo, Ying, Wei, Chaofeng, Guan, Lu, Ju, Wenhan, Lian, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327183/
https://www.ncbi.nlm.nih.gov/pubmed/37420272
http://dx.doi.org/10.1186/s13048-023-01200-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327183/
https://www.ncbi.nlm.nih.gov/pubmed/37420272
http://dx.doi.org/10.1186/s13048-023-01200-7

Ejemplares similares